Tina S. Nova - 15 Jun 2023 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
Executive Chairperson, Director
Signature
/s/ Kamal Adawi, Attorney-in-Fact
Issuer symbol
XGN
Transactions as of
15 Jun 2023
Net transactions value
$0
Form type
4
Filing time
20 Jun 2023, 16:30:50 UTC
Previous filing
15 Feb 2023
Next filing
13 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XGN Stock Option(right to buy) Award $0 +13,500 $0.000000 13,500 15 Jun 2023 Common Stock 13,500 $3.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The entire number of shares subject to this option becomes fully vested and exercisable on the earlier of June 9, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date.